Guggenheim Capital LLC Gsk PLC Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$42.05 - $47.77 $609,136 - $691,996	-14,486 Reduced 27.66%	37,884 $1.65 Million
Q1 2022 May 16, 2022	SELL	$40.23 - $47.74 $428,328 - $508,287	-10,647 Reduced 16.9%	52,370 $2.28 Million
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $260,884 - $304,030	6,710 Added 11.92%	63,017 $2.78 Million
Q3 2021 Nov 15, 2021	BUY	$38.79 - $43.16 $142,979 - $159,087	3,686 Added 7.0%	56,307 $2.15 Million
Q2 2021 Aug 13, 2021	BUY	$36.52 - $41.46 $106,236 - $120,607	2,909 Added 5.85%	52,621 $2.1 Million
Q1 2021 May 13, 2021	SELL	$34.27 - $40.01 $149,417 - $174,443	-4,360 Reduced 8.06%	49,712 $1.78 Million
Q4 2020 Feb 16, 2021	BUY	$34.07 - $39.94 $4,054 - $4,752	119 Added 0.22%	54,072 $1.99 Million
Q3 2020 Nov 13, 2020	SELL	$38.11 - $42.99 $340,284 - $383,857	-8,929 Reduced 14.2%	53,953 $2.03 Million
Q2 2020 Aug 14, 2020	BUY	$37.87 - $43.58 $61,728 - $71,035	1,630 Added 2.66%	62,882 $2.57 Million
Q1 2020 Jun 02, 2020	SELL	$32.47 - $48.83 $163,648 - $246,103	-5,040 Reduced 7.6%	61,252 $2.32 Million
Q4 2019 Feb 14, 2020	SELL	$42.0 - $48.25 $10,416 - $11,966	-248 Reduced 0.37%	66,292 $3.12 Million
Q3 2019 Nov 14, 2019	SELL	$40.46 - $43.52 $450,764 - $484,856	-11,141 Reduced 14.34%	66,540 $2.84 Million
Q2 2019 Aug 14, 2019	SELL	$39.4 - $42.7 $987,994 - $1.07 Million	-25,076 Reduced 24.4%	77,681 $3.11 Million
Q1 2019 May 15, 2019	SELL	$38.57 - $42.69 $479,656 - $530,892	-12,436 Reduced 10.8%	102,757 $4.29 Million
Q4 2018 Feb 14, 2019	SELL	$37.8 - $42.69 $1.37 Million - $1.54 Million	-36,156 Reduced 23.89%	115,193 $4.4 Million
Q3 2018 Nov 14, 2018	SELL	$39.75 - $42.69 $145,445 - $156,202	-3,659 Reduced 2.36%	151,349 $6.08 Million
Q2 2018 Aug 14, 2018	BUY	$39.61 - $42.76 $35,886 - $38,740	906 Added 0.59%	155,008 $6.25 Million
Q1 2018 May 15, 2018	BUY	$36.18 - $40.15 $479,819 - $532,469	13,262 Added 9.42%	154,102 $6.02 Million
Q4 2017 Feb 14, 2018	SELL	$35.34 - $41.9 $2.46 Million - $2.92 Million	-69,709 Reduced 33.11%	140,840 $5 Million
Q3 2017 Nov 14, 2017	BUY	$39.44 - $41.55 $8.3 Million - $8.75 Million	210,549	210,549 $8.55 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account